Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Huawei Pharmaceutical Co., Ltd. (also known as Hangzhou Warwick Pharmaceutical) is a modern Chinese patent medicine pharmaceutical company founded in 2001 and based in Fuyang District, Hangzhou, China. The company specializes in the research, development, manufacturing, and commercialization of traditional Chinese medicine (TCM) preparations across nine dosage forms, including oral liquids, syrups, tablets, granules, and mixtures. Its product portfolio features over 30 approved drug products, notably 'Yinling Mixture' (银灵合剂), a national exclusive anti-tumor TCM, 'Gaoshanhongjingtian Oral Liquid' (高山红景天口服液) for hypoxia and fatigue, and 'Yikang Tablet' (宜康片) for diabetes. Hangzhou Huawei Pharmaceutical operates a large-scale, GMP-certified manufacturing facility spanning approximately 100,000 square meters to support its extensive commercial operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Huawei Pharmaceutical.